4th Quarter - Report

PHARMATHENE, INC for PHARMATHENE, INC

Firm
Client
Income
—
Expenses
$177,386
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Pandemic All-Hazards preparedness Act (PAHPA) Reauthorization; Biomedical Advanced Research and Development Authority (BARDA) funding at HHS for 2011; Education on threat of bioterrorism and urgency for development of Medical Countermeasures (MCM's) including new, modern recombinant Protective Antigen anthrax vaccine (rPA), anthrax antitoxin monoclonal antibody therapeutic and chemical nerve agent bioscavenger.

LobbyistCovered position, as disclosed
MARK EDWARD COOKE Sr. Director Government Affairs

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Health & Human Services, Dept of (HHS)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.